Infections and cancer
PRINCIPAL INVESTIGATORS
- Francesc Xavier Bosch Jose
- Laia Bruni Coccoz
- Miguel Angel Pavon Ribas
- Raquel Ibañez Pérez
- Laura Costas Caudet
- Assumpta Company Serrat
- Delphine Casabonne
CLINICAL RESEARCHERS
- Maria Brotons Agulló
- Maria Eulalia Fernandez Montoli
POSTDOCTORAL RESEARCHERS
- Marisa Mena Cervigón
- Beatriz Quirós Blasco
- Mireia Díaz Sanchís
- Claudia Robles Hellin
- Álvaro Carmona Pestaña
- Ginesa Albero Abril
- Sònia Paytubi Casabona
PREDOCTORAL RESEARCHERS
- David Gómez Guillén
- Jon Frias Gomez
- Beatriz Serrano Carro
- Maryam Choulli Amgait
- Paula Àngela Peremiquel Trillas
- Alvaro De Andres Pablo
SCIENTIFIC SUPPORT
- Francisco Javier Ruiz Carrasco
- Olga Romero Clara
- Joan Valls Marsal
- Frederic Rodilla Pamies
- Jesus Muñoz Villanueva
- Maria Gema Carretero Garcia
- Sara Hermosa Garcia
- Juan José Collado Contreras
- Ainhoa Botella Cayuelas
- Victoria Lopez Codony
- Maria Del Pilar Vidaurre Teixidó
- Yolanda Florencia Melgarejo
- Francisca Morey Cortes
- Vanesa Camon Melguizo
- Alexandra Montoliu Gimenez
- Sara Tous Belmonte
- Laura Monfil Herrera
- Laura Asensio Puig
- Esther Roura Fornells
- Ana Esteban Miró
- Marleny Vergara Muñoz
- Yolanda Benavente Moreno
- Irene Onieva Hernandez
- Victoria Porthé Reggiardo
- Antonio Sanchez Baos
- Beatriz Thais Pelegrina Sanchez-Dehesa
- Omar Clavero Carletti
- Valentina Rangel Sarmiento
MANAGEMENT SUPPORT
- Maite Carvajal Restoy
- Marta Lopez Querol
- Natividad Paton Morales
- Diana Salinas Hidalgo
- Mireia Montserrat Moreno
- Arnau Guasch Girbau
Cancer
EPIBELL
Scientific production
30
PAPERS
Average IF: 8,835
11
LED PAPERS
Average IF: 10,58
10 PUBLICATIONS IN FIRST DECILE
24 PUBLICATIONS IN FIRST QUARTILE
21 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Mehanna,H;Taberna,M;von Buchwald,C;Tous,S;Brooks,J;Mena,M;Morey,F et al, Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis, Lancet Oncol., 2023;24(3):239-251, doi:10.1016/S1470-2045(23)00013-X
- Bruni,L;Albero,G;Rowley,J;Alemany,L;Arbyn,M;Giuliano,AR;Markowitz,LE et al, Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis, Lancet Glob. Health, 2023;11(9):1345-1362, doi:10.1016/S2214-109X(23)00305-4
- Costas,L;Onieva,I;Pelegrina,B;Marin,F;Carmona,A;López Querol,M;Frias Gomez,J et al, Evaluation of Somatic Mutations in Urine Samples as a Noninvasive Method for the Detection and Molecular Classification of Endometrial Cancer, Clin. Cancer Res., 2023;29(18):3681-3690, doi:10.1158/1078-0432.CCR-23-0367
- Pelegrina,B;Paytubi,S;Marin,F;Martinez,JM;Carmona,A;Frias Gomez,J;Peremiquel Trillas,P et al, Evaluation of somatic mutations in cervicovaginal samples as a non-invasive method for the detection and molecular classification of endometrial cancer, EBioMedicine, 2023;94104716-104716, doi:10.1016/j.ebiom.2023.104716
- Frias Gomez,J;Alemany,L;Benavente,Y;Clarke,MA;de Francisco,J;De Vivo,I;Du,M et al, Night shift work, sleep duration and endometrial cancer risk: A pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2)., Sleep Med Rev, 2023;72101848-101848, doi:10.1016/j.smrv.2023.101848
Research highlights
PROJECTS
7 Granted competitive projects
22 Ongoing competitive projects
1 Started clinical trial
5 Ongoing clinical trials
2 Ongoing non-competitive projects
NETWORKS
AGAUR SGR GRC
CIBERESP
Selected projects
- CEE21039. PERCH: PartnERship to Contrast HPV. COMISSIÓ EUROPEA. Budget: 409.468,03€. 2022-2025. PI: Brotons Agulló, Maria.
- 20CEE006. RISCC: RISK-BASED SCREENING FOR CERVICAL CANCER. COMISSIÓ EUROPEA. Budget: 378.125€. 2020-2024. PI: Bosch José, Francesc Xavier.
- 19CEE002. HEADSpAcE: Translational studies of HEAD and neck cancer in South America and Europe. COMISSIÓ EUROPEA. Budget: 249.985€. 2019-2024. PI: Alemany Vilches, Maria Eulalia.
- 19ACL260. ENSAYO CLÍNICO EN FASE 3, INTERNACIONAL, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA ESTUDIAR LA EFICACIA, LA INMUNOGENICIDAD Y LA SEGURIDAD DE LA VACUNA 9VVPH, UNA VACUNA POLIVALENTE DE PARTÍCULAS VIROIDES L1, EN LA PREVENCIÓN DE LA INFECCIÓN BUCAL PERSISTENTE POR LOS TIPOS 16, 18, 31, 33, 45, 52 O 58 DEL VPH EN VARONES ADULTOS DE 20 A 45 AÑOS DE EDAD. MERCK SHARP & DOHME ESPAÑA S.A. Budget: 224.455€. 2020- . PI: Alemany Vilches, Maria Eulalia.
- MCI22005. WOMEC ADVANCED : NUEVAS APROXIMACIONES PARA EL DIAGNÓSTICO DE CÁNCER DE ENDOMETRIO. Ministerio de Ciencia e Innovación. Budget: 194.288€. 2022-2025. PI: Costas Caudet, Laura.